Papers
2
Total Citations
122
H-Index
2
About
Hua Li is a multifaceted biomedical researcher whose work spans two distinct but equally impactful domains: molecular oncology and minimally invasive pancreatic surgery. In cancer biology, Li made significant contributions to understanding cell cycle regulation in lung cancer, most notably through a 2009 study that revealed previously unrecognized consequences of targeting the cyclin E-Cdk-2 complex, demonstrating that disrupting this molecular partnership triggers anaphase catastrophe and suppresses tumor growth — work that has accumulated 67 citations and holds important implications for lung cancer therapy and chemoprevention. Complementing this mechanistic work, Li has also advanced surgical oncology, particularly in the realm of robotic-assisted pancreatic procedures. A 2016 retrospective analysis from a high-volume Asian center examined robotic enucleation as a parenchyma-sparing alternative to conventional pancreatectomy for benign or borderline pancreatic tumors, earning 55 citations and helping establish best practices for organ-preserving surgery that reduces risks of exocrine and endocrine insufficiency. Together, these contributions reflect a researcher committed to improving cancer outcomes through both molecular insights and innovative surgical technique.
Research Focus
Key Achievements
Top Papers
- 1
- 2